Form 4 for LMAT LEMAITRE VASCULAR INC
Accepted 2026-01-12 00:00:00 ET · period of report 2026-01-08 · accession 0001193125-26-010637 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-01-12 | 2026-01-08 | LMAT | Kamke Trent G | Senior V. P, Ops | M - OptEx | $42.67 | +2,344 | 6,761 | +53% | +$100.0K |
| DM | 2026-01-12 | 2026-01-08 | LMAT | Kamke Trent G | Senior V. P, Ops | M - OptEx | $0.00 | -2,344 | 5,085 | -32% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-08 | M | A | 1,229 | $37.29 | 5,646 | D | — | — | (F1) Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. |
| 2 | Common | Common Stock | 2026-01-08 | M | A | 1,115 | $48.60 | 6,761 | D | — | — | (F1) Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. |
| 3 | Derivative | Stock Option (Right to Buy) | 2026-01-08 | M | D | 1,229 | $0.00 | 3,690 | D | $37.29 · 2020-12-02 to 2027-12-02 | 1,229 Common Stock | (F2) This option is fully vested and exercisable. |
| 4 | Derivative | Stock Option (Right to Buy) | 2026-01-08 | M | D | 1,115 | $0.00 | 5,085 | D | $48.60 · 2021-12-11 to 2028-12-11 | 1,115 Common Stock | (F2) This option is fully vested and exercisable. |